CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will participate on a panel entitled "Invest Globally: A Framework for Building Great Companies" at the CED's Globalization 2008 Conference
News | 02. 14. 2008
